CRONYXIN INJECTION 50 MG/ML SOLUTION FOR INJECTION

Nazione: Irlanda

Lingua: inglese

Fonte: HPRA (Health Products Regulatory Authority)

Principio attivo:

FLUNIXIN MEGLUMINE

Commercializzato da:

Bimeda Chemicals

Codice ATC:

QM01AG90

INN (Nome Internazionale):

FLUNIXIN MEGLUMINE

Dosaggio:

50 Mg/Ml

Forma farmaceutica:

Solution for Injection

Tipo di ricetta:

POM

Gruppo terapeutico:

Bovine, Equine - Food

Area terapeutica:

Flunixin

Indicazioni terapeutiche:

N.S.A.I.D

Stato dell'autorizzazione:

Authorised

Data dell'autorizzazione:

1996-02-20

Scheda tecnica

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Cronyxin Injection 50 mg/ml Solution for Injection
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
For a full list of excipients, see Section 6.1.
3 PHARMACEUTICAL FORM
A clear, colourless solution for injection.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle and horses.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
CATTLE: For the control of acute inflammation associated with respiratory disease. Cronyxin Injection may be used as
adjunctive therapy in the treatment of acute mastitis.
HORSES: For the alleviation of inflammation and pain associated with musculoskeletal disorders. It is also indicated for
the alleviation of visceral pain associated with colic.
4.3 CONTRAINDICATIONS
Do not use in animals suffering from cardiac, hepatic or renal disease, where there is the possibility of gastro-intestinal
ulceration or bleeding, where there is evidence of a blood dyscrasia or hypersensitivity to the product.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Avoid use in dehydrated, hypovolaemic or hypotensive animals, as there is a potential risk of increased renal toxicity.
Each ml contains:
ACTIVE SUBSTANCE:
Flunixin (as Flunixin Meglumine) 50.0 mg
EXCIPIENTS:
Phenol Ph.Eur.
5.0 mg
Sodium formaldehyde sulfoxylate
2.2 mg
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 07/01/2016_
_CRN 7022590_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
NSAIDs can cause inhibition of phagocytosis and hence in the treatment of inflammatory conditions associated with
bacterial infections, appropriate concurrent antimicrobial therapy should be instigated.
Avoid intra-arterial injection.
Some NSAIDs�